Phase III study of F901318 for invasive aspergillosis

Trial Profile

Phase III study of F901318 for invasive aspergillosis

Planning
Phase of Trial: Phase III

Latest Information Update: 11 Jul 2016

At a glance

  • Drugs F 901318 (Primary)
  • Indications Aspergillosis
  • Focus Registrational; Therapeutic Use
  • Sponsors F2G
  • Most Recent Events

    • 11 Jul 2016 According to an F2G media release, the company plans to initiate this trial in 1H 2017.
    • 24 Jun 2016 New trial record
    • 20 Jun 2016 According to F2G media release, thae company plans to initiate this trial in the second half of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top